Prasad on Medicine

• 21st Century Physician: Triaging the Tsunami of Medical Information Vinay Prasad describes his essential tips to separate fact from spin in medical studies.
  Medscape Oncology, September 2018
• 'Twitter Cheerleaders': A Megaphone for Bad Science A new class of physician has emerged in the era of social media: cheerleaders who hype new cancer drugs on Twitter. But what we desperately need are realistic scientific appraisals, argues Vinay Prasad.A new class of physician has emerged in the era of social media: cheerleaders who hype new cancer drugs on Twitter. But what we desperately need are realistic scientific appraisals, argues Vinay Pra
  Medscape Oncology, September 2018
• When Do We Need RCTs, and When Can We Manage Without Them? A recent debate on Twitter over the use of inferior vena cava filters reinforces the value of conducting randomized controlled trials in medicine, argues Dr Vinay Prasad.
  Medscape Oncology, August 2018
• FDA's Genomic Screening Approval Blurs Research and Practice   The FDA's approval of broad genomic testing for patients with cancer will bring unproven therapies into clinical practice, argues Vinay Prasad.
  Medscape Oncology, June 2018
• Calling Out the FDA's 'We Don't Regulate Medicine' Mantra Dr Vinay Prasad calls the FDA to task over the differing standards the agency uses to grant drug approvals and expanded indications.
  Medscape Oncology, May 2018
• Vinay Prasad: Why I'm Writing for Medscape Vinay Prasad introduces his new Medscape column.
  Medscape Oncology, May 2018